These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12831108)

  • 1. Responding to the Competition Commission's report.
    Scott-Park F
    J Small Anim Pract; 2003 Jun; 44(6):289-90. PubMed ID: 12831108
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidance on the Competition Commission's recommendations.
    Vet Rec; 2005 Nov; 157(20):607. PubMed ID: 16284323
    [No Abstract]   [Full Text] [Related]  

  • 3. Facing competition on veterinary medicines supply.
    Vet Rec; 2004 Apr; 154(14):417-8. PubMed ID: 15119890
    [No Abstract]   [Full Text] [Related]  

  • 4. Competition Commission points to complex monopolies in the supply of POMs.
    Vet Rec; 2002 Sep; 151(12):338-9. PubMed ID: 12371688
    [No Abstract]   [Full Text] [Related]  

  • 5. Competition Commission's investigation into POMs.
    Wray JG
    Vet Rec; 2002 Apr; 150(17):554. PubMed ID: 12019539
    [No Abstract]   [Full Text] [Related]  

  • 6. DTI consults on legislation to improve competition in the POMs market.
    Vet Rec; 2005 Feb; 156(9):262-3. PubMed ID: 15765892
    [No Abstract]   [Full Text] [Related]  

  • 7. Competition Commission recommendations: plans for implementation.
    Vet Rec; 2005 Sep; 157(11):302-3. PubMed ID: 16155233
    [No Abstract]   [Full Text] [Related]  

  • 8. Practices can stop displaying lists of 'top 10' medicines.
    Vet Rec; 2013 Mar; 172(11):277. PubMed ID: 23504154
    [No Abstract]   [Full Text] [Related]  

  • 9. Competition Commission's inquiry into the supply of animal POMs.
    Jinman P
    Vet Rec; 2002 Mar; 150(10):322-3. PubMed ID: 11913591
    [No Abstract]   [Full Text] [Related]  

  • 10. Competition in the supply of medicines.
    Lister SA
    Vet Rec; 2004 Apr; 154(16):511; discussion 511-2. PubMed ID: 15130061
    [No Abstract]   [Full Text] [Related]  

  • 11. Competition Commission identifies issues for further consideration.
    Vet Rec; 2002 Apr; 150(16):494-6. PubMed ID: 12017523
    [No Abstract]   [Full Text] [Related]  

  • 12. Veterinary pharmaceuticals--an endangered species?
    Vet Rec; 2001 Oct; 149(17):508. PubMed ID: 11708634
    [No Abstract]   [Full Text] [Related]  

  • 13. Availability of medicines.
    McMullin P
    Vet Rec; 1997 Nov; 141(19):503. PubMed ID: 9402725
    [No Abstract]   [Full Text] [Related]  

  • 14. Supply of POMs.
    Jinman P
    Vet Rec; 2003 Jun; 152(26):814-5. PubMed ID: 12862173
    [No Abstract]   [Full Text] [Related]  

  • 15. Moves to eliminate 'anticompetitive' practices in the supply of prescription-only veterinary medicines.
    Vet Rec; 2003 Apr; 152(16):482-4. PubMed ID: 12733556
    [No Abstract]   [Full Text] [Related]  

  • 16. Privilege to dispense.
    Flower PJ
    Vet Rec; 2001 Feb; 148(7):219. PubMed ID: 11266006
    [No Abstract]   [Full Text] [Related]  

  • 17. Independent review group calls for greater transparency in the dispensing of medicines.
    Vet Rec; 2001 May; 148(20):611-4. PubMed ID: 11394794
    [No Abstract]   [Full Text] [Related]  

  • 18. Supply of veterinary medicines.
    Treves-Brown KM
    Vet Rec; 2003 May; 152(20):635. PubMed ID: 12790173
    [No Abstract]   [Full Text] [Related]  

  • 19. Supply of veterinary medicines.
    Anthony FJ; Baker KB; Miller DJ; Young RC; Baird JH
    Vet Rec; 2003 May; 152(20):635. PubMed ID: 12790174
    [No Abstract]   [Full Text] [Related]  

  • 20. From the supply of POMs to proposed changes in the BVA's structure.
    Vet Rec; 2003 May; 152(19):575-6. PubMed ID: 12762485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.